Related content

Copy number variation and warfarin dosing: evaluation of CYP2C9, VKORC1, CYP4F2, GGCX and CALU

By Scott Stuart A   Patel Manishkumar   Martis Suparna   Lubitz Steven A   van der Zee Sarina   Yoo Chang   Edelmann Lisa   Halperin Jonathan L   Desnick Robert J  

Pharmacogenomics, Vol. 13, Iss. 3, 2012-02 ,pp. : 297-307

Future Medicine

Access to resources Recommend Favorite

Association of Genetic Polymorphisms of CYP2C9 and VKORC1 with Bleeding Following Warfarin: A Case-Control Study

By  

Current Clinical Pharmacology, Vol. 11, Iss. 1, 2016-02 ,pp. : 62-68

Bentham Science Publishers

Access to resources Recommend Favorite

Dosing algorithm for warfarin using CYP2C9 and VKORC1 genotyping from a multi-ethnic population: comparison with other equations

By Wu Alan HB   Wang Ping   Smith Andrew   Haller Christine   Drake Katherine   Linder Mark   Valdes Roland  

Pharmacogenomics, Vol. 9, Iss. 2, 2008-02 ,pp. : 169-178

Future Medicine

Access to resources Recommend Favorite

Combined CYP2C9, VKORC1 and CYP4F2 frequencies among racial and ethnic groups

By Scott Stuart A   Khasawneh Rame   Peter Inga   Kornreich Ruth   Desnick Robert J  

Pharmacogenomics, Vol. 11, Iss. 6, 2010-06 ,pp. : 781-791

Future Medicine

Access to resources Recommend Favorite

CYP4F2 genetic variant (rs2108622) significantly contributes to warfarin dosing variability in the Italian population

By Borgiani Paola   Ciccacci Cinzia   Forte Vittorio   Sirianni Elisabetta   Novelli Lucia   Bramanti Placido   Novelli Giuseppe  

Pharmacogenomics, Vol. 10, Iss. 2, 2009-02 ,pp. : 261-266

Future Medicine

Access to resources Recommend Favorite